Evaluation the Feasibility of the FOSTI Device
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Feasibility of accurate differentiation between malignant and benign tissue using the FOSTI device on surgically removed tissue
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 13, 2008
CompletedFirst Posted
Study publicly available on registry
November 14, 2008
CompletedNovember 14, 2008
November 1, 2008
November 13, 2008
November 13, 2008
Conditions
Keywords
Eligibility Criteria
The study population will consist of subjects who undergo cancer surgery
You may qualify if:
- Subjects of all ages.
- Subject is able, agree and sign the Informed Consent Form.
You may not qualify if:
- Subject has any conditions, which precludes compliance with study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Optivasive Ltd.lead
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Anatoliy Babchenko
Optivasive Ltd.
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 13, 2008
First Posted
November 14, 2008
Study Start
March 1, 2008
Last Updated
November 14, 2008
Record last verified: 2008-11